BioCentury
ARTICLE | Company News

Acura, King deal

November 5, 2007 8:00 AM UTC

KG received an exclusive license from ACUR to commercialize Acurox (formerly OxyADF) tablets and an undisclosed opioid product using ACUR's Aversion abuse-deterrent technology in North America. Acuro...